LEADER 03841nam 2200673 450 001 9910799000103321 005 20200520144314.0 010 $a3-11-049277-6 010 $a3-11-049192-3 024 7 $a10.1515/9783110492774 035 $a(CKB)3710000000908411 035 $a(MiAaPQ)EBC4718421 035 $a(DE-B1597)469473 035 $a(OCoLC)960976807 035 $a(OCoLC)979585364 035 $a(DE-B1597)9783110492774 035 $a(Au-PeEL)EBL4718421 035 $a(CaPaEBR)ebr11283248 035 $a(CaONFJC)MIL964184 035 $a(PPN)201846101 035 $a(EXLCZ)993710000000908411 100 $a20161026h20162016 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 10$aRunes and Roman letters in Anglo-Saxon manuscripts /$fVictoria Symons 210 1$aBerlin, [Germany] :$cDe Gruyter,$d2016. 210 4$dİ2016 215 $a1 online resource (236 pages) 225 1 $aErga?nzungsba?nde zum Reallexikon der Germanischen Altertumskunde,$x1866-7678 ;$vBand 99 311 $a3-11-049474-4 320 $aIncludes bibliographical references and index. 327 $tFrontmatter -- $tAcknowledgements -- $tTable of contents -- $tList of Abbreviations -- $tIntroduction -- $t1. Runes in Old English Manuscripts: The Exeter Book Manuscript as a Case Study -- $t2. Reading and Writing in the Runic Riddles and The Husband's Message -- $t3. Cynewulf's Signatures and the Materiality of the Letter -- $t4. The Power of the Letter in Runic Charms and Solomon and Saturn I -- $t5. Rune Lists and Alphabet Poems: Studying the Letter in Later Anglo-Saxon England -- $t6. Conclusion -- $tBibliography -- $tIndex 330 $aThis book presents the first comprehensive study of Anglo-Saxon manuscript texts containing runic letters. To date there has been no comprehensive study of these works in a single volume, although the need for such an examination has long been recognized. This is in spite of a growing academic interest in the mise-en-page of early medieval manuscripts. The texts discussed in this study include Old English riddles and elegies, the Cynewulfian poems, charms, Solomon and Saturn I, and the Old English Rune Poem. The focus of the discussion is on the literary analysis of these texts in their palaeographic and runological contexts. Anglo-Saxon authors and scribes did not, of course, operate within a vacuum, and so these primary texts are considered alongside relevant epigraphic inscriptions, physical objects, and historical documents. Victoria Symons argues that all of these runic works are in various ways thematically focused on acts of writing, visual communication, and the nature of the written word. The conclusion that emerges over the course of the book is that, when encountered in the context of Anglo-Saxon manuscripts, runic letters consistently represent the written word in a way that Roman letters do not. 410 0$aErga?nzungsba?nde zum Reallexikon der germanischen Altertumskunde ;$vBand 99. 606 $aInscriptions, English (Old) 606 $aInscriptions, Runic$zGreat Britain 606 $aManuscripts, English (Old) 606 $aPaleography$xHistory$yTo 1500 610 $aCyncewulf. 610 $aOld English. 610 $aRunology. 610 $ascript-mixing. 615 0$aInscriptions, English (Old) 615 0$aInscriptions, Runic 615 0$aManuscripts, English (Old) 615 0$aPaleography$xHistory 676 $a429/.11 686 $aNC 1600$2rvk 700 $aSymons$b Victoria$f1986-$01520767 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910799000103321 996 $aRunes and Roman letters in Anglo-Saxon manuscripts$93759533 997 $aUNINA LEADER 03515nam 2200625 450 001 9910830371803321 005 20230721005314.0 010 $a1-4443-0333-3 010 $a1-4443-0334-1 035 $a(CKB)1000000000722805 035 $a(EBL)416357 035 $a(OCoLC)476247457 035 $a(SSID)ssj0000104238 035 $a(PQKBManifestationID)11140788 035 $a(PQKBTitleCode)TC0000104238 035 $a(PQKBWorkID)10079636 035 $a(PQKB)11394892 035 $a(MiAaPQ)EBC416357 035 $a(EXLCZ)991000000000722805 100 $a20160805h20092009 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aAntiplatelet therapy in ischemic heart disease /$fStephen D. Wiviott 210 1$aHoboken, New Jersey :$cWiley-Blackwell,$d2009. 210 4$dİ2009 215 $a1 online resource (311 p.) 225 1 $aAmerican Heart Association Clinical Series 300 $aIncludes index. 311 $a1-4051-7626-1 327 $aContents; Contributors; Preface; Foreword; PART I: Concepts in Platelet Physiology, Function, and Measurement; 1 Platelet physiology and the role of the platelet in ischemic heart disease; 2 Laboratory assessment of platelet function and the effects of antiplatelet agents; PART II: Pharmacology of Oral Antiplatelet Agents; 3 Cyclooxygenase inhibitors; 4 Aspirin response variability and resistance; 5 P2Y[sub(12)] inhibitors: Thienopyridines and direct oral inhibitors; 6 Thienopyridine response variability and resistance; PART III: Pharmacology of Intravenous Antiplatelet Agents 327 $a7 Pharmacology of intravenous glycoprotein IIb/IIIa antagonists8 Intravenous P2Y[sub(12)] inhibitors; 9 Antiplatelet effects of thrombin inhibitors and fibrinolytic agents; PART IV: Clinical Use of Antiplatelet Agents in Cardiovascular Disease; 10 Antiplatelet therapy in acute coronary syndrome without ST elevation; 11 Antiplatelet therapy in ST-elevation myocardial infarction; 12 Antiplatelet therapy in chronic coronary artery disease; 13 Antiplatelet therapy in peripheral arterial disease; 14 Clinical use of antiplatelet agents in cardiovascular disease: cerebrovascular diseases 327 $aPART V: Special Circumstances15 Antiplatelet therapy and coronary bypass surgery: risks and benefits; 16 Management of antiplatelet therapy for non-cardiac surgery; 17 Antiplatelet therapy and coronary stents; Index; A; B; C; D; E; F; G; H; I; J; K; L; M; N; O; P; R; S; T; U; V; W; Author Disclosure Table 330 $a* Draws from expertise of leaders in antiplatelet therapy* Easy-to-use layout enables rapid browsing* Edited by a member of the prestigious TIMI study group with long-standing experience in the field 410 0$aAmerican Heart Association monograph. 606 $aCoronary heart disease$xChemotherapy 606 $aBlood platelets$xAggregation 606 $aCoronary heart disease$xdrug therapy 615 0$aCoronary heart disease$xChemotherapy. 615 0$aBlood platelets$xAggregation. 615 0$aCoronary heart disease$xdrug therapy. 676 $a616.12306 676 $a616.123061 700 $aWiviott$b Stephen D.$01342498 701 $aWiviott$b Stephen D$01342498 712 02$aAmerican Heart Association. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910830371803321 996 $aAntiplatelet therapy in ischemic heart disease$94047776 997 $aUNINA